Regaining compliance with Nasdaq's listing requirements is a significant positive development for Jin Medical International. It not only removes the immediate risk of delisting but also can improve investor sentiment towards the company's stock. This news is directly related to the company's ability to meet regulatory standards, which is often viewed positively by the market. The impact on the stock price is likely to be positive in the short term as it reassures investors about the company's governance and financial reporting quality.